Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | -3.31% | -2.78% | -41.86% |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Apr. 02 | Certain Warrants of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024. | CI |
Business Summary
Number of employees: 186
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dermatology Products
93.7
%
| 74 | 97.3 % | 79 | 93.7 % | +7.48% |
Pharmaceutical and Biotechnology Product Development
6.3
%
| 2 | 2.7 % | 5 | 6.3 % | +157.09% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 76 | 100.0 % | 85 | 100.0 % | +11.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 69 | 09-09-30 | |
David Jin
DFI | Director of Finance/CFO | 34 | - |
Michael Weiss
BRD | Director/Board Member | 58 | 13-12-19 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Samuel Berry
LAW | General Counsel | - | 16-05-31 |
Brian Achenbach
AUD | Comptroller/Controller/Auditor | 59 | 17-11-13 |
Corporate Officer/Principal | 71 | 13-06-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 69 | 09-09-30 | |
Michael Weiss
BRD | Director/Board Member | 58 | 13-12-19 |
J. Lobell
BRD | Director/Board Member | 61 | 06-05-31 |
Eric Rowinsky
BRD | Director/Board Member | 67 | 10-09-30 |
Jimmie Harvey
BRD | Director/Board Member | 72 | 08-11-30 |
Malcolm Hoenlein
BRD | Director/Board Member | 80 | 14-02-19 |
Xiao Qin Lu
BRD | Director/Board Member | 49 | 22-12-13 |
Dov Klein
BRD | Director/Board Member | 72 | 15-06-30 |
Kevin Lorenz
BRD | Director/Board Member | 59 | 19-08-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,234,526 | 14,174,368 ( 73.69 %) | 0 | 73.69 % |
Stock B | 0 | 3,427,138 | 0 | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
JOURNEY MEDICAL CORPORATION 100.00% | 6,000,000 | 100.00% | 22,080,000 $ |
MUSTANG BIO, INC. 19.85% | 1,894,463 | 19.85% | 1,970,242 $ |
700,000 | 7.54% | 1,435,000 $ | |
3,547,393 | 8.01% | 521,467 $ |
Company contact information
Fortress Biotech, Inc.
1111 Kane Concourse Suite 301
33154, Bay Harbor Islands
+781 652 4500
http://www.fortressbiotech.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.86% | 33.66M | |
-5.99% | 83.66B | |
+2.76% | 40.41B | |
-24.88% | 28.26B | |
+53.61% | 24.53B | |
-8.08% | 16.82B | |
-33.74% | 13.39B | |
-16.63% | 11.75B | |
-11.19% | 11.69B | |
-2.25% | 8.13B |
- Stock Market
- Equities
- FBIO Stock
- Company Fortress Biotech, Inc.